We are live on
!
Find out more
Balyasny Asset Management Portfolio holdings
AUM
$77.1B
1-Year Est. Return
42.89%
This Fund
S&P 500
This Quarter
Est. Return
+4.63%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+763.65%
AUM
$77.1B
AUM Growth
-$1.68B
(-2.1%)
Cap. Flow
-$2.68B
Cap. Flow
% of AUM
-3.48%
Top 10 Holdings %
Top 10 Hldgs %
16.75%
Holding
3,716
New
704
Increased
979
Reduced
1,056
Closed
911
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$626M |
| 2 |
Warner Bros
WBD
|
+$447M |
| 3 |
Apple
AAPL
|
+$436M |
| 4 |
RTX Corp
RTX
|
+$434M |
| 5 |
Constellation Brands
STZ
|
+$320M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.13B |
| 2 |
Microsoft
MSFT
|
+$502M |
| 3 |
RNAM
Avidity Biosciences
RNAM
|
+$436M |
| 4 |
EXAS
Exact Sciences
EXAS
|
+$415M |
| 5 |
Electronic Arts
EA
|
+$388M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.75% |
| 2 | Industrials | 9.36% |
| 3 | Consumer Discretionary | 8.52% |
| 4 | Healthcare | 7.75% |
| 5 | Financials | 7.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1576
iShares US Home Construction ETF
ITB
$2.32B
| $2.7M | ﹤0.01% |
29,871
+24,886
| +499% | +$2.55M |
|
1577
Celldex Therapeutics
CLDX
$2.94B
| $2.7M | ﹤0.01% |
+85,026
| New | +$2.32M |
|
1578
PUT
Enovix
ENVX
$803M
| $2.69M | ﹤0.01% |
+520,000
| New | +$3.25M |
|
1579
HNI Corp
HNI
$3.08B
| $2.69M | ﹤0.01% |
80,489
-193,472
| -71% | -$8.57M |
|
1580
SPDR Gold Trust
GLD
$131B
| $2.69M | ﹤0.01% |
6,245
+3,054
| +96% | +$1.37M |
|
1581
CALL
American Airlines Group
AAL
$9.82B
| $2.69M | ﹤0.01% |
+250,000
| New | +$3.31M |
|
1582
Gulfport Energy Corp
GPOR
$2.82B
| $2.68M | ﹤0.01% |
12,688
+9,171
| +261% | +$1.82M |
|
|
TLN
1583
CALL
Talen Energy Corp
TLN
$15.1B
| $2.68M | ﹤0.01% |
+8,400
| New | +$2.96M |
|
|
ARIS
1584
Aris Mining
ARIS
$2.87B
| $2.68M | ﹤0.01% |
144,114
-172,872
| -55% | -$3.27M |
|
|
GTY
1585
Getty Realty Corp
GTY
$2.16B
| $2.66M | ﹤0.01% |
83,614
+36,701
| +78% | +$1.15M |
|
1586
PUT
Align Technology
ALGN
$12.9B
| $2.66M | ﹤0.01% |
15,500
+11,300
| +269% | +$1.98M |
|
1587
First Commonwealth Financial
FCF
$2.2B
| $2.65M | ﹤0.01% |
150,750
+138,969
| +1,180% | +$2.45M |
|
1588
NNN REIT
NNN
$9.29B
| $2.64M | ﹤0.01% |
62,916
-18,356
| -23% | -$791K |
|
1589
Abeona Therapeutics
ABEO
$355M
| $2.64M | ﹤0.01% |
589,847
-1,890
| -0.3% | -$9.45K |
|
1590
PayPal
PYPL
$49.9B
| $2.64M | ﹤0.01% |
58,417
-2,092
| -3% | -$101K |
|
|
MOB
1591
Mobilicom Ltd
MOB
$54.8M
| $2.64M | ﹤0.01% |
513,206
+252,994
| +97% | +$1.62M |
|
1592
PUT
US Bancorp
USB
$97.9B
| $2.64M | ﹤0.01% |
50,700
-136,600
| -73% | -$7.51M |
|
1593
PUT
Western Digital
WDC
$159B
| $2.62M | ﹤0.01% |
9,700
-20,400
| -68% | -$5.33M |
|
1594
Elicio Therapeutics
ELTX
$75.9M
| $2.62M | ﹤0.01% |
244,814
+106,052
| +76% | +$1.02M |
|
|
SPRB
1595
Spruce Biosciences
SPRB
$114M
| $2.61M | ﹤0.01% |
40,000
| – | – |
|
1596
PUT
YPF
YPF
$19.7B
| $2.61M | ﹤0.01% |
+56,500
| New | +$2.14M |
|
1597
Takeda Pharmaceutical
TAK
$56.7B
| $2.6M | ﹤0.01% |
140,578
-446
| -0.3% | -$7.83K |
|
1598
Nektar Therapeutics
NKTR
$2.39B
| $2.58M | ﹤0.01% |
35,851
-246,170
| -87% | -$14M |
|
|
UNIT
1599
Uniti Group
UNIT
$2.52B
| $2.58M | ﹤0.01% |
274,893
+232,662
| +551% | +$1.82M |
|
|
MPT
1600
Medical Properties Trust
MPT
$2.84B
| $2.58M | ﹤0.01% |
556,374
+424,312
| +321% | +$2.21M |
|
Similar funds
CBU
BC
Balyasny Asset Management's Q1 2026 Portfolio in Review
As of Q1 2026, Balyasny Asset Management held 3,716 positions worth $77.1B, down 2.1% from $78.8B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Balyasny Asset Management withdrew a net $2.68B in Q1 2026, closing 911 positions and reducing 1,056 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $1.13B position sold in full.
By sector, the portfolio is most concentrated in Technology at 9.7% of assets, down from 12% a quarter earlier, followed by Industrials and Consumer Discretionary.
Against the trend, Balyasny Asset Management opened a new position in Silicon Laboratories worth $257M.
- Balyasny Asset Management's largest Q1 2026 buy was Silicon Laboratories: 1,233,893 shares worth $257M.
- Balyasny Asset Management added most to Meta Platforms (Facebook) in Q1 2026, an estimated $626M increase.
- Balyasny Asset Management's biggest Q1 2026 reduction was Microsoft, cutting an estimated $502M.
- Balyasny Asset Management fully exited iShares Core S&P 500 ETF in Q1 2026, selling an estimated $1.13B.
- Balyasny Asset Management's ten largest holdings make up 17% of its $77.1B portfolio in Q1 2026.
- Balyasny Asset Management opened 704 new positions and closed 911 in Q1 2026.
- Balyasny Asset Management's portfolio value fell 2.1% quarter-over-quarter to $77.1B.
Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.